sharecast

{{ storiesRelated.title }}

AstraZeneca (AZN)

6,351.00p

15:39 22/03/19

  • -2.67% -174.00p
  • Today's Low & High
  • 6,335.00 / 6,468.00
  • Open / Previous Close
  • 6,468.00 / 6,351.00
  • 52-week range
  • 31.40% 1,517.50p
  • Volume
  • 1,499,191
  • Market Cap(million)
  • £80,485.44m

6,355.00p REAL TIME BATS

  • 16:30 22/03/19
  • -2.67%
  • -174.00p

KEY FINANCIALS

  Latest Forecast
Div Yield 3.3% 3.4%
Div Cover 1.2 1.3
Op Mrgn 16.1% 23.3%
ROCE 103.5%  
  Latest Forecast
P/E 24.2 22.8
PEG -1.3 6.9
Price / Revenue 5.1 4.4
Price / Book value 7.6  
  Latest Forecast
Revenue 4.5% 0.0%
PBT -10.5% n/a
EPS -19.2% 0.0%
DPS 0.0% 0.0%

KEY FUNDAMENTALS

Year Ending Revenue
($m)		 Pre-tax
($m)		 EPS P/E PEG EPS Growth Div Yield
2014-12-31 26,095.00 1,246.00 $4.28 16.6 -1.1 -15% $2.80 3.9%
2015-12-31 23,641.00 3,069.00 $4.26 16.0 -34.2 0% $2.80 4.1%
2016-12-31 21,319.00 3,552.00 $4.31 12.7 10.8 1% $2.80 5.1%
2017-12-31 20,152.00 2,227.00 $4.28 16.2 -23.2 -1% $2.80 4.0%
2018-12-31 21,049.00 1,993.00 $3.46 21.6 -1.1 -19% $2.80 3.7%

FORECAST

Year Ending Revenue
($m)		 Pre-tax
($m)		 EPS P/E PEG EPS Growth Div Yield
2019-12-31 18,187.04 4,242.13 269.14p 22.8 6.7 3% 215.10p 3.4%
2020-12-31 20,011.19 4,898.81 329.93p 18.7 0.8 23% 217.46p 3.5%

Latest Webfg News

Monday broker round-up Sharecast News 18 Mar
FDA grants orphan drug designation to AstraZeneca's 'saracatinib' Sharecast News 18 Mar
Tuesday broker round-up Sharecast News 12 Mar

Regulatory News

US FDA grants saracatinib ODD for IPF 18-Mar-19 07:04
Notice of AGM 14-Mar-19 12:01
Director/PDMR Shareholding 12-Mar-19 12:01
Filing of Form 20-F with SEC 06-Mar-19 07:03
Annual Financial Report 05-Mar-19 11:00